Screening and prevention of HPV ‐related anogenital cancers in women living with HIV in Europe : Results from a systematic review
HIV Medicine · 2024
DOI: 10.1111/hiv.13602 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift HIV Medicine, 2024. Verfasst von Dagny Krankowska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, Warszawa, Poland. Hauptthemen laut MEDLINE: Papillomavirus Infections, HIV Infections, Anus Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: EACS.
Abstract (Originalsprache)
Background
Women living with HIV (WLWH) are at increased risk of human papillomavirus (HPV)‐related cancers. Throughout Europe, there is great heterogeneity among guidelines for screening programmes, access to HPV testing and HPV vaccination. The aim of this systematic review is to summarize available data on screening and prevention measures for HPV‐related anogenital cancers in WLWH across the WHO European Region (WER).
Methods
The systematic review followed the PRISMA guidelines and was registered on Prospero. PubMed, Embase and Web of Science databases were searched to identify available studies, written in English and published between 2011 and 2022. A metanalysis was conducted using random‐effects models to calculate pooled prevalence of HPV. Subgroup analyses were conducted according to country and HPV testing.
Results
Thirty‐four articles involving 10 336 WLWH met the inclusion criteria. Studies were heterogenous in their methodology and presentation of results: 73.5% of studies focused on cervical cancer prevention, and only 4.4% on anal cancer; 76.5% of studies conducted HPV testing as a routine part of screening. The prevalence of high‐risk HPV was 30.5–33.9% depending on the detection method used. A total of 77% of WLWH had cervical cytology results reported. Six studies reported the positive association of CD4 cell count
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, Warszawa, Poland.
- Hospital for Infectious Diseases in Warsaw, Warsaw, Poland.
- Infectious and Tropical Diseases Unit, Padua University Hospital, Padua, Italy.
- CPL Life Science, Hurley, UK.
- Centro Sanitario Sandoval, Hospital Clinico San Carlos, IdlSSC, Madrid, Spain.
- Karadeniz Technical University School of Medicine, Trabzon, Turkey.
ORCID-Profile: Dagny Krankowska, Maria Mazzitelli, Hazal Albayrak Ucak, Eva Orviz, Hanife Nur Karakoc, Karoline Aebi-Popp, Yvonne Gilleece
Förderung
- EACS
Zitieren
APA
Krankowska, D., Mazzitelli, M., Ucak, H. A., Orviz, E., Karakoc, H. N., Mortimer, H., Aebi-Popp, K., & Gilleece, Y. (2024). Screening and prevention of HPV ‐related anogenital cancers in women living with HIV in Europe : Results from a systematic review. HIV Medicine. https://doi.org/10.1111/hiv.13602
Vancouver
Krankowska D, Mazzitelli M, Ucak HA, Orviz E, Karakoc HN, Mortimer H, et al. Screening and prevention of HPV ‐related anogenital cancers in women living with HIV in Europe : Results from a systematic review. HIV Medicine. 2024. doi:10.1111/hiv.13602
BibTeX
@article{Krankowska2024,
author = {Krankowska, Dagny and Mazzitelli, Maria and Ucak, Hazal Albayrak and Orviz, Eva and Karakoc, Hanife Nur and Mortimer, Harriet and Aebi-Popp, Karoline and Gilleece, Yvonne},
title = {Screening and prevention of HPV ‐related anogenital cancers in women living with HIV in Europe : Results from a systematic review},
journal = {HIV Medicine},
year = {2024},
doi = {10.1111/hiv.13602}
}
EUVIMED